A group of 125 patients with unstable angina were studied over a S-year period to define the incidence of refractory unstable angina in the current era of S-drug medical therapy with intravenous heparht, aspirin, nitrates, caldum antagonists and fl blockers. All patients had >26 minutes of chest pain at rest with reversible ekctrocardiographic changes occurring in the absence of myocardial infarction. Patients were considered refractory only if chest pain continued despite treatment with maximal I-drug therapy.
U >750,000 hospitalizations annually in the United States1 With conventional antianginal therapy, up to 15% of patients develop myocardial infarction in the hospital. 2 Recent studies suggest that routine use of intravenous heparin and aspirin signiticantly reduces morbidity and mortality in patients hospitalized with unstable angina. 3,4 Urgent revascularization by coronary angioplasty or bypass grafting has an increased complication rate in patients with unstable angina pectoris. 5, 6 However, patients with unstable angina refractory to medical therapy are at high risk for in-hospital cardiac events and should be most strongly considered for urgent revascularization. The incidence and outcomes of refractory unstable angina in the contemporary setting of maximal antianginal, antiplatelet and anticoagulant therapy is unknown. We sought to define the incidence of refractory unstable angina in a group of patients with unstable angina transferred to our tertiary care facility for consideration of coronary revascularization.
METHODS
. Sele&on of patie&sr Five hundred and two patients referred to the University of Michigan Hospital with the diagnosis of unstable angina between January 1, 1986 and January 1, 1991 were analyzed retrospectively. Patients were included in the study provided that they: (1) were transferred from an outside hospital after being admitted with chest pain at rest of >20 minutes duration; (2) had reversible electrocardiographic changes with chest pain, including >l mm ST-segment depression or elevation or T-wave inversion in 2 limb or contiguous precordial leads; (3) had peak creatine kinase levels <2 times the upper limits of normal; and (4) underwent an attempt at medical stabilization before transfer.
One hundred twenty-five patients fulfilled the inclusion criteria and constituted the study population (Figure 1) . Baseline data abstracted from the clinical record on these patients included: (1) history of stable angina pectoris, myocardial infarction or congestive heart failure; (2) history of myocardial revascularization; (3) character and location of electrocardiographic changes with chest pain; (4) medical regimen at transfer; (5) maximal medical regimen at University of Michigan; (6) duration of medical therapy before resolution of chest pain or before patient was considered refractory; and (7) results of cardiac catheterization including coronary anatomy (stenoses considered significant if 270%) and left ventricular ejection fraction.
Maximal medical therspy: Maximal medical therapy was considered treatment with a combination of as- 
RESULTS
In all, 502 patients with "unstable angina" were transferred to the University of Michigan Hospital during the study period ( Figure 1 ). The following groups of patients were excluded from this cohort: 17 transferred directly for revascularization without attempts at medical stabilization; 28 with evidence of myocardial infarction; 51 without chest pain at rest; and 281 after review of the records did not document reversible electrocardiographic changes with chest pain. Inclusion criteria were fulfilled by 125 patients. Chest pain resolved with medical therapy in 60 of these patients before transfer. Chest pain at rest with ischemic electrocardiographic changes continued in 65 patients who were considered medically refractory by their referring physicians. A more aggressive medical regimen was used at the University of Michigan, and 54 (83%) of these patients be came free of chest pain. Only 11 patients (8.8%) ultimately proved refractory to maximal medical therapy.
Demographic and dinieal data: Table I shows characteristics of the 11 patients with refractory unstable angina compared with the 114 who stabilized with medical therapy. No significant differences were found be tween the groups regarding age, sex, history of stable angina pectoris or myocardial infarction, and left ventricular function. Patients with refractory unstable angina were more likely to have had prior coronary artery bypass grafting. Patients with refractory unstable angina had persistent chest pain despite an average of 9 days of maximal (5-drug) medical therapy, whereas those responding to medical therapy with resolution of chest pain did so in an average of 4 days (p = 0.01). Patients with refractory unstable angina were more likely to have anterior electrocardiographic changes with chest pain (7 of 11 vs 25 of 114; p = 0.008). Inferior electrocardiographic changes with chest pain were not seen in the refractory group (p = 0.03). T-wave inversion with chest pain was more often seen in patients who stabilized on medical therapy (p = 0.05). All patients underwent cardiac catheterization. Refractory patients had an increased likelihood of left main or 3-vesse1 coronary artery disease (7 of 11 vs 26 of 114; p = 0.01). A >70% stenosis of the left main coronary artery was identified in 5 of 11 patients in the refractory group and in 2 of 114 in the medically stabilized group. In-hospital myocardial infarction or death was significantly more frequent in the refractory group (4 of 11 vs 9 of 114; p = 0.009). Hospital course (refractory unstable angina paWrits): All 11 patients with refractory unstable angina underwent revascularization. Coronary angioplasty was performed in 4 patients with refractory angina. One patient had abrupt closure and subsequent non-Q-wave myocardial infarction. One patient with a large dissection of the left anterior descending coronary artery died the day after angioplasty with a cardiac arrest. There were 7 refractory patients treated with bypass grafting. Two patients died after surgery; 1 could not be weaned from cardiopulmonary bypass, and 1 died 1 day after surgery from ventricular fibrillation. One patient had a perioperative myocardial infarction. Hospital courw (stabwad pa@nts): The hospital course of the 114 medically stabilized patients included continued medical therapy in 37, coronary angioplasty in 46, and bypass grafting in 31. Table III shows that the groups were similar in duration of medical therapy before resolution of chest pain, number of drugs used to achieve medical stabilization, and left ventricular function. Patients with left main or 3-vessel coronary artery disease were more likely to undergo bypass grafting during hospitalization, whereas those with l-or 2-vessel coronary artery disease were more often treated with continued medical therapy or coronary angioplasty. Table IV shows the hospital course of the 114 patients with unstable angina who became free of chest pain with medical therapy. Stabilized patients managed with continued medical therapy (n = 37) were chest pain-free an average of 7 days before discharge. No patient in this group had a myocardial infarction and 1 (2.7%) died during hospitalization. Recurrent stable angina developed in 3 patients (8.1%) and was controlled by alterations in medical therapy. Coronary angioplasty was performed in 46 medically stabilized patients before discharge. Indications for coronary angioplasty included: (1) coronary anatomy considered high risk for future cardiac events (n = 42; 91%); (2) ischemia on prediicharge exercise testing (n = 3; 6.7%); and (3) recurrent exertional angina (n = 1; 2.2%). Coronary angioplasty was performed an average of 6 days after the onset of unstable angina and 4 days after the last episode of chest pain. Angioplasty was successful in 92% of cases. Abrupt closure complicated 12 of 46 procedures (26%). Emergency bypass grafting was needed in 3 patients (6.5%), 4 (8.7%) had postprocedural myocardial infarction, and 1 (2.2%) died after angioplasty. After angioplasty, the incidence of emergency bypass grafting, myocardial infarction or death was 17%.
Bypass grafting was performed in 31 medically stabilized patients before discharge. Indications for surgery included: (1) coronary anatomy considered high risk for future cardiac events (n = 26; 84%); (2) ischemia on predischarge exercise testing (n = 2; 6%); and (3) recurrent exertional angina (n = 3; 10%). One patient had a perioperative myocardial infarction, and there were 2 deaths after surgery.
Myocardial infarction or death occurred in 3% of patients managed medically, in 11% treated with coronary angioplasty and in 9% who underwent bypass grafting. Patients revascularized by coronary angioplasty or bypass grafting tended to be discharged with less medical therapy.
DISCUSSION
Atherosclerotic plaque rupture with concomitant platelet aggregation and thrombus formation is believed to be the underlying mechanism for the development of acute coronary syndromes7y8 Most studies assessing morbidity and mortality in patients hospitalized with unstable angina were performed before routine use of intravenous heparin and aspirin. Conventional therapy of patients hospitalized with unstable angina with nitrates, fl blockers or calcium antagonists reduces the number of ischemic episodes, but does not reduce the frequency of myocardial infarction (13%) or death (4%).9-l3 Both aspirin3,4J2J3 and intravenous heparin3,4 have been shown to reduce the rate of myocardial infarction and death in patients hospitalized with unstable angina.
Gur findings show that "true" refractory unstable angina is infrequent (<9%) with aggressive contemporary medical therapy, including combinations of antianginal, anticoagulant and antiplatelet agents. Theroux et al3 showed a 23% incidence of refractory angina in patients hospitalized with resting or accelerating angina managed with nitrates, /3 blockers or calcium antagonists. When intravenous heparin with or without aspirin was used, a 9.6% incidence of refractory angina was observed. Most patients in our study considered medically refractory at transfer were medically undertreated. Of patients considered medically refractory who were transferred to our hospital for urgent revascularization, most (83%) became free of chest pain on a more aggressive medical regimen. Only one third of these pseudorefractory patients were receiving intravenous heparin, and surprisingly, 30% were not receiving aspirin therapy.
Persistence of chest pain in patients hospitalized with unstable angina despite maximal medical therapy predicts a poor outcome, with a 51% incidence of early infarction or death.14 All refractory patients in this study underwent revascularization by either coronary angioplasty or bypass grafting. However, a 36% rate of in-hospital myocardial infarction or death was still observed.
The hospital treatment strategies for medically stabilized patients included continued medical management, coronary angioplasty and bypass grafting. Several prior studies showed that patients with unstable angina who become chest pain-free with medical therapy have a low rate of in-hospital cardiac events, with a 1 to 2% mortality rate and a 7 to 9% rate of myocardial infarction.i4J5 In the study by Theroux et al3 and the Research Group on Instability in Coronary Artery Disease in Southeast Sweden (RISC) trial,4 the use of intravenous heparin and aspirin in combination with antianginal therapy in the treatment of patients hospitalized with unstable angina resulted in a 1.5% rate of myocardial infarction or death. Medically stabilized patients in our study whose treatment strategy consisted of continued medical therapy had a low rate (30%) of in-hospital myocardial infarction or death. Rapid progression of the underlying coronary stenosis is known to occur in most patients after an episode of unstable angina, with 30 to 50% redeveloping angina and crossing over to revascularization by 1 year. l6 Frequently cited predictors of poor long-term outcome in patients with unstable angina managed medically include left main or 3-vessel coronary artery disease, decreased left ventricular function, abnormal baseline electrocardiogram, prior myocardial infarction, reperfusion abnormality on thallium imaging, and silent ischemia on continuous ambulatory monitoring.17-20 Thus, although most patients hospitalized with unstable angina do not need urgent revascularization for relief of chest pain, recurrent angina1 symptoms after discharge are common.
Coronary angioplasty within the first 1 to 2 weeks after the onset of unstable angina has an increased complication rate.5p16,21-26 Angioplasty in this setting of intraluminal thrombus2' carries a significantly higher rate of abrupt closure.28 A review of the studies of coronary angioplasty in unstable angina shows a major complication rate (myocardial infarction, emergent bypass grafting or death) of 10 to 26%.5J6J1-26 Treatment of these patients with 3 to 5 days of intravenous heparin in preparation for coronary angioplasty may decrease this complication rate.29j0 Myler et al5 found that angioplasty in patients within the first 2 weeks after the onset of unstable angina is associated with a lower initial success rate and a two to threefold increased risk for myocardial infarction, need for emergency bypass grafting, death or development of late recurrent angina. The high complication rate and poor outcome for coronary angioplasty in patients with unstable angina in our study (26% abrupt closure rate, and 17% incidence of myocardial infarction, emergency bypass grafting or death) supports the contention that early coronary angioplasty in unstable angina has a complication event rate that may exceed the natural history of adverse cardiac events occurring in this population when managed conservatively with medical therapy.23 An increased operative mortality has also been reported when coronary artery bypass grafting is performed in patients with unstable angina. 6 The rate of myocardial infarction or death in this study for medically stabilized patients undergoing bypass grafting before hospital discharge was 9%.
Comparisons between treatment strategies (medical management, coronary angioplasty and bypass grafting) of the medically stabilized patients are not possible, because of the retrospective nature of this study. Because our hospital serves as a referral center, the characteristics of patients with unstable angina in this study may differ from those presenting to other hospitals. Furthermore, with the inclusion criteria selecting only patients with prolonged angina at rest and electrocardiographic changes, the high complication rate of coronary angioplasty may not reflect the results of angioplasty in patients with new-onset or accelerating unsta-
